StockData
Pharming Group N.V. logo

Pharming Group N.V. (PHAR) stock

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30
$12.48+0.42 (+3.51%)

Close on Nov 18, 2026Market cap $875.92MP/E 312.1Yield –

Pharming pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Pharming's pe ratio was 335.0× on Nov 11, 2026, against 60.8× a year earlier. Over the last 4 years it ranged from 14.6× to 416.0×, with a median of 53.1×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026335.0×+274.7
2024Feb 29, 202460.3×+0.1
2023Dec 29, 202360.2×+12.2
2022Dec 30, 202248.0×+31.7
2021Dec 31, 202116.3×−9.1
2020Dec 31, 202025.3×–

More Pharming figures

See a number that looks wrong?